We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $138M
1-Year Est. Return 7.66%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$238M
AUM Growth
+$25.7M
Cap. Flow
+$5.05M
Cap. Flow %
2.13%
Top 10 Hldgs %
35.47%
Holding
116
New
16
Increased
25
Reduced
31
Closed
25

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$5.97M
2
TJX icon
TJX Companies
TJX
+$4.98M
3
PFE icon
Pfizer
PFE
+$4.01M
4
CB icon
Chubb
CB
+$2.74M
5
PG icon
Procter & Gamble
PG
+$2.64M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.34M
2
WRB icon
W.R. Berkley
WRB
+$3.36M
3
DLTR icon
Dollar Tree
DLTR
+$3.31M
4
RF icon
Regions Financial
RF
+$2.99M
5
KDP icon
Keurig Dr Pepper
KDP
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 30.3%
2 Financials 12.53%
3 Healthcare 12.28%
4 Consumer Discretionary 9.74%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$16.3M 6.85%
84,502
MSFT icon
2
Microsoft
MSFT
$3.45T
$16.2M 6.82%
43,079
-3,747
-8% -$1.33M
AMZN icon
3
Amazon
AMZN
$2.92T
$8.09M 3.41%
53,257
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$6.67M 2.81%
47,354
-2,894
-6% -$393K
CB icon
5
Chubb
CB
$135B
$6.51M 2.74%
28,796
+12,532
+77% +$2.74M
PFE icon
6
Pfizer
PFE
$143B
$6.42M 2.7%
222,870
+132,761
+147% +$4.01M
BIIB icon
7
Biogen
BIIB
$30B
$6.29M 2.65%
+24,322
New +$5.97M
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.36T
$6.11M 2.57%
43,711
-1,838
-4% -$247K
ADBE icon
9
Adobe
ADBE
$99.5B
$5.9M 2.48%
9,891
+1,178
+14% +$679K
DLR icon
10
Digital Realty Trust
DLR
$69.7B
$5.8M 2.44%
43,121
+4,590
+12% +$593K
WFC icon
11
Wells Fargo
WFC
$261B
$5.72M 2.41%
116,203
+48,723
+72% +$2.1M
ZBH icon
12
Zimmer Biomet
ZBH
$18.2B
$5.67M 2.39%
46,598
-187
-0.4% -$20.9K
NVDA icon
13
NVIDIA
NVDA
$4.86T
$5.51M 2.32%
111,300
+12,140
+12% +$563K
TJX icon
14
TJX Companies
TJX
$174B
$5.21M 2.19%
+55,557
New +$4.98M
BAX icon
15
Baxter International
BAX
$13.5B
$5M 2.1%
129,323
GM icon
16
General Motors
GM
$80.4B
$4.88M 2.06%
136,002
+16,146
+13% +$499K
WEC icon
17
WEC Energy
WEC
$35.7B
$4.36M 1.84%
51,850
+21,102
+69% +$1.74M
AMAT icon
18
Applied Materials
AMAT
$403B
$4.13M 1.74%
25,460
+970
+4% +$143K
ADSK icon
19
Autodesk
ADSK
$49.5B
$3.71M 1.56%
15,254
+4,079
+37% +$881K
TXN icon
20
Texas Instruments
TXN
$252B
$3.69M 1.55%
21,629
-31
-0.1% -$4.8K
CSCO icon
21
Cisco
CSCO
$457B
$3.57M 1.5%
70,601
+36,541
+107% +$1.87M
PNC icon
22
PNC Financial Services
PNC
$99.7B
$3.5M 1.47%
22,610
QCOM icon
23
Qualcomm
QCOM
$155B
$3.48M 1.47%
24,065
-53
-0.2% -$6.56K
V icon
24
Visa
V
$684B
$3.46M 1.46%
13,301
-31
-0.2% -$7.64K
VZ icon
25
Verizon
VZ
$195B
$3.41M 1.43%
90,339
+28,156
+45% +$996K

Similar funds

Stoneridge Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Stoneridge Investment Partners held 116 positions worth $238M, up 12% from $212M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stoneridge Investment Partners's Q4 2023 filing shows 16 new, 25 increased, 31 reduced and 25 closed positions. Its largest new stake was Biogen: 24,322 shares worth $6.29M. The largest sale was CVS Health, an estimated $6.34M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • Stoneridge Investment Partners's largest Q4 2023 buy was Biogen: 24,322 shares worth $6.29M.
  • Stoneridge Investment Partners added most to Pfizer in Q4 2023, an estimated $4.01M increase.
  • Stoneridge Investment Partners's biggest Q4 2023 reduction was Salesforce, cutting an estimated $2.42M.
  • Stoneridge Investment Partners fully exited CVS Health in Q4 2023, selling an estimated $6.34M.
  • Stoneridge Investment Partners's ten largest holdings make up 35% of its $238M portfolio in Q4 2023.
  • Stoneridge Investment Partners opened 16 new positions and closed 25 in Q4 2023.
  • Stoneridge Investment Partners's portfolio value rose 12% quarter-over-quarter to $238M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.